Preliminary institutional evaluation of a new drug in cerebral palsy: N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate (soma).
D002328:Carisoprodol; D002547:Cerebral Palsy / Q000628:therapy*; D006268:Health Facilities; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D019946:Propylene Glycol; D011409:Propylene Glycols
D009125:Muscle Relaxants, Central; D011409:Propylene Glycols; D002328:Carisoprodol; C041787:1,3-propanediol; D019946:Propylene Glycol
CEREBRAL PALSY/therapy; MUSCLE RELAXANTS/therapeutic use